Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Major Depressive Disorder Clinical Trials

25 recruiting trials for Major Depressive Disorder. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
25
Total Trials
25
Recruiting Now
5
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06080646

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses...

Sponsor: San Francisco Veterans Affairs Medical CenterEnrolling: 1501 location
RECRUITINGPhase 3NCT06966401

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With...

This study will evaluate the long-term safety and tolerability of NBI-1065845 as an adjunctive treatment in participants with MDD.

Sponsor: Neurocrine BiosciencesEnrolling: 60018 locations
RECRUITINGNCT06897670

Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared...

The purpose of this research is to measure brain activity in individuals with mood disorders and memory problems using a simple, safe, and noninvasive method called functional...

Sponsor: Mayo ClinicEnrolling: 2001 location
RECRUITINGPhase 3NCT06911112

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants...

The study will evaluate the efficacy of NBI-1065845 compared with placebo as an adjunctive treatment in participants with MDD on improving symptoms of depression.

Sponsor: Neurocrine BiosciencesEnrolling: 20010 locations
RECRUITINGNCT06076317

Relevance of a Telemedicine Monitoring in the Management of Depression

Major depressive disorder (MDD) is a common chronic disease. It is the main cause of morbidity and disability in the world with, among other things, an increase in...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 8361 location
RECRUITINGPhase 3NCT04041479

Biomarker-guided rTMS for Treatment Resistant Depression

Repetitive transcranial magnetic stimulation (rTMS) is a treatment for depression. The investigators are continuing to learn how to optimize outcomes from rTMS treatment. The...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 3482 locations
RECRUITINGPhase 3NCT06247839

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder

This open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in...

Sponsor: Sharmin GhaznaviEnrolling: 201 location
RECRUITINGNCT04576182

Supportive-Expressive and Emotion-Focused Treatment for Depression

This study will explore the mechanisms of change that are activated when individuals receive a treatment that targets their weakness and the mechanisms activated when the...

Sponsor: University of HaifaEnrolling: 1241 location
RECRUITINGPhase 2NCT06132178

Psilocybin rTMS for Treatment Resistant Depression

The purpose of this study is to determine the safety and feasibility of sequencing psilocybin therapy with a short-duration, aiTBS protocol (Stanford Accelerated Intelligent...

Sponsor: University of Texas at AustinEnrolling: 1001 location
RECRUITINGPhase 2NCT06236880

A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

This is a three-part Phase 2a study. The aim of Part A is to assess the safety and tolerability and preliminary antidepressant efficacy in patients with MDD who are not currently...

Sponsor: Gilgamesh PharmaceuticalsEnrolling: 1241 location
RECRUITINGNCT06968390

Accelerated TMS for Perinatal Depression

We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form...

Sponsor: Brigham and Women's HospitalEnrolling: 241 location
RECRUITINGNCT02734602

Imaging SV2A in Mood Disorders

This study is designed to examine SV2A density in MDD and PTSD as a correlate of synaptic density, and to determine whether ketamine administration will reverse the synaptic loss...

Sponsor: Yale UniversityEnrolling: 1301 location
RECRUITINGNCT03601026

Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use

Severe mental illness (SMI) refers to the most burdensome psychiatric conditions. The need to pre-empt the onset of SMI is pressing because once SMI develops, quality of life is...

Sponsor: Nova Scotia Health AuthorityEnrolling: 1201 location
RECRUITINGPhase 4NCT07105111

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain...

This study will evaluate the efficacy of valbenazine on clinician- and patient-reported outcomes in participants with TD while receiving or after stopping a VMAT2 inhibitor.

Sponsor: Neurocrine BiosciencesEnrolling: 508 locations
RECRUITINGPhase 3NCT05603104

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a...

Schizophrenia, bipolar and major depressive disorders collectively affect over 10 million people across the EU and are associated with annual healthcare and societal costs in...

Sponsor: Dr. Inge WinterEnrolling: 12541 location
RECRUITINGPhase 4NCT06417437

Non-invasive BCI and Application Verification for Depressed People

Major Depressive Disorder (MDD) is a serious mental illness and public health problem that poses threat to both physical and mental health. According to statistics from WHO, it is...

Sponsor: Shanghai Mental Health CenterEnrolling: 4001 location
RECRUITINGPhase 4NCT04828226

Clonidine to Prevent Delirium After Electroconvulsive Therapy.

Electroconvulsive therapy (ECT) is a highly effective treatment for some psychiatric disorders like major depressive or bipolar disorder, but may lead to agitation and delirium...

Sponsor: Insel Gruppe AG, University Hospital BernEnrolling: 1301 location
RECRUITINGNCT06700902

Taking Action for College Students

The goal of this research is to investigate whether a peer-delivered illness self-management program called Taking Action can help college students with serious mental illnesses....

Sponsor: Temple UniversityEnrolling: 3001 location
RECRUITINGNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These...

Sponsor: Mark NiciuEnrolling: 10001 location
RECRUITINGNCT05384405

aiTBS for Relieving NSSI in Depressive Patients

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries...

Sponsor: Central South UniversityEnrolling: 601 location
RECRUITINGNCT03953014

Pharmacogenetics of Antidepressant-Induced Disinhibition

The purpose of this study is to identify pharmacogenetic profiles associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioral disinhibition in children with...

Sponsor: University of CalgaryEnrolling: 1201 location
RECRUITINGPhase 2NCT06376734

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

Participants will receive Transcranial Magnetic Stimulation (TMS) at a random location in the left prefrontal cortex, excluding sites that are potentially unsafe. Extensive...

Sponsor: Brigham and Women's HospitalEnrolling: 1802 locations
RECRUITINGNCT06763081

Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation

The purpose of this study is to identify and validate a panel of genetic markers associated with selective serotonin reuptake inhibitors (SSRI)-induced behavioural activation in...

Sponsor: University of ManitobaEnrolling: 1602 locations
RECRUITINGNCT07219394

Peer-Delivered Behavioral Activation in a CCBHC

Low-income individuals have limited access to evidence-based interventions for mental health. Peer recovery specialists, individuals in recovery from mental health and/or...

Sponsor: Wayne State UniversityEnrolling: 2501 location
RECRUITINGNCT06086366

Presynaptic Imaging in Major Depressive Episodes After COVID-19

The goal of this observational study focuses on understanding and addressing a subset of persistent neuropsychiatric symptoms occurring within 3 months after mild to moderate...

Sponsor: Centre for Addiction and Mental HealthEnrolling: 901 location